Insider Selling: Vitalhub (TSE:VHI) Director Sells 150,000 Shares of Stock

Key Points

• Danny Matlow, a director at Vitalhub Corp., sold 150,000 shares of the company's stock, representing a 22.39% decrease in ownership.
• Following the sale, Matlow holds 520,001 shares valued at approximately C$6.63 million, as the stocks were sold at an average price of C$12.75.
• Multiple research firms have raised their price targets for Vitalhub, with consensus opinions leading to a target price of C$14.08 and an overall rating of "Buy" for the stock.

Vitalhub Corp. (TSE:VHI - Get Free Report) Director Danny Matlow sold 150,000 shares of Vitalhub stock in a transaction on Thursday, August 28th. The shares were sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the completion of the sale, the director owned 520,001 shares in the company, valued at approximately C$6,630,012.75. This trade represents a 22.39% decrease in their position.

Vitalhub Trading Down 0.9%

TSE VHI traded down C$0.10 during trading on Friday, hitting C$11.09. The company had a trading volume of 134,896 shares, compared to its average volume of 151,120. Vitalhub Corp. has a one year low of C$8.30 and a one year high of C$14.64. The company has a market cap of C$696.78 million, a price-to-earnings ratio of 138.63, a price-to-earnings-growth ratio of 1.18 and a beta of 0.93. The company's fifty day moving average is C$12.67 and its 200-day moving average is C$11.06.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on VHI. TD Securities increased their price target on shares of Vitalhub from C$15.00 to C$16.00 and gave the stock a "buy" rating in a research note on Monday, August 11th. National Bank Financial raised Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. Scotiabank lifted their price target on Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research report on Friday, June 20th. National Bankshares set a C$16.00 price target on Vitalhub and gave the stock an "outperform" rating in a research note on Thursday, August 21st. Finally, Raymond James Financial increased their price objective on Vitalhub from C$14.50 to C$15.00 and gave the stock an "outperform" rating in a report on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of C$14.08.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.